Davidson Kempner Partners’s Starling Oncology, Inc. Warrant STLNW Stock Holding History

Davidson Kempner Partners’s Portfolio STLNW Stock Details STLNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$19.3K	Buy	+318,710	New	+$39.4K	﹤0.01%	285

Other funds holding STLNW

LMR Partners London, United Kingdom $45.4B AUM 60.47% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

DCM

Difesa Capital Management New York $38.1M AUM 39.86% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Davidson Kempner Partners's STLNW Position: Q1 2023 in Review

Davidson Kempner Partners opened a new position in Starling Oncology, Inc. Warrant (STLNW) in Q1 2023: 318,710 shares worth $19.3K. The stake represents ﹤0.01% of the portfolio and ranks #285 among its holdings.

15 funds tracked by Wall St. Rank hold STLNW as of Q1 2023.

Davidson Kempner Partners held 318,710 shares of Starling Oncology, Inc. Warrant worth $19.3K as of Q1 2023.
Starling Oncology, Inc. Warrant was a new Davidson Kempner Partners position in Q1 2023.
Starling Oncology, Inc. Warrant made up ﹤0.01% of Davidson Kempner Partners's portfolio in Q1 2023, its #285 holding.
15 funds tracked by Wall St. Rank held Starling Oncology, Inc. Warrant as of Q1 2023.

Based on Davidson Kempner Partners's 13F filing for Q1 2023, filed 15 May 2023.